Hi folks: I have been invested in CYDY since 2016. My opinion is that the team is working very diligently to make sure all of the sections of the BLA are answered in a comprehensive manner so that the FDA will be more efficient in the review and approval process. I do not think that we should be over-reacting until we know what if anymore delays occur. I work in healthcare and have over 35 years in the provider and payer space. Nothing happens as fast as we want, expect, or in comparison to other industries. As all of us know patience is a virtue and we have started to see the results in our stock price over the past 45 days! NP has been transparent and I believe he will continue to communicate with all of us. I so appreciate everyone’s insights and opinions on this board and look forward to our continued progress in SP and uplifting. All in my opinion.